Support Vector Machines (SVMs), and other supervised learning techniques have been experimented for the bio-molecular diagnosis of malignancies, using also feature selection methods. The classification task is particularly difficult because of the high dimensionality and low cardinality of gene expression data. In this paper we investigate a different approach based on random subspace ensembles of SVMs: a set of base learners is trained and aggregated using subsets of features randomly drawn from the available DNA microarray data. Experimental results on the colon adenocarcinoma diagnosis and medulloblastoma clinical outcome prediction show the effectiveness of the proposed approach.
Introduction
When the diagnosis of malignancies depend on multiple bio-molecular factors, traditional clinical diagnostic approaches may sometimes fail [1] High throughput bio-technologies based on large scale hybridization techniques (e.g. DNA microarray) are able to produce information to support both diagnosis and prognosis of malignancies at bio-molecular level, but the problem of extracting significant knowledge from the data becomes critical because of the peculiar Email addresses: bertoni@dsi.unimi.it (Alberto Bertoni), folgieri@dico.unimi.it (Raffaella Folgieri), valentini@dsi.unimi.it (Giorgio Valentini).
characteristics of gene expression data. In fact, DNA microarray data are usually characterized by a small number of vectors of high dimension that give rise to the so called curse of dimensionality problem [2] .
A possible approach to reduce the dimensionality consists in applying feature selection methods [3] . Considering that feature selection is a NP-hard problem [4] , we experiment with an alternative approach based on random subspace ensembles [5] , using linear SVMs as base learners. Indeed it has been shown that linear SVMs are effective both as base learners in random subspace ensembles [6] , and as classifiers for gene expression-based diagnosis of cancer [7] .
Random subspace ensembles for gene expression data analysis
Recently ensemble methods have been successfully applied to the bio-molecular diagnosis of tumors [8, 9] .
In particular random subspace ensembles seem to be well-suited to the characteristics of gene expression data, as they reduce the high dimensionality of the data by randomly selecting subsets of genes, in presence of dependencies among co-regulated genes [1] . Moreover, aggregating the resulting base classifiers trained on different subsets of gene expression levels, we may improve diversity between base learners, without a substantial loss of accuracy due to the redundancy of the available gene expression data.
At a high level, the random subspace ensemble method [5] is characterized by three steps:
(2) Each new data set D i is given in input to a fixed learning algorithm L which outputs the classifiers h i for all i,
The final classifier h is obtained by aggregating the base classifiers h 1 , ..., h n through majority voting.
Experimental results
We have experimented with the method on 2 bio-medical problems, both based on gene expression profiles of a relatively small group of patients: 1) Colon adenocarcinoma bio-molecular diagnosis [10] 2) Medulloblastoma clinical outcome prediction [11] . We extended the NEURObjects library [12] , adding new C++ classes and developing applications for random subspace ensembles.
Colon tumor prediction
The Colon adenocarcinoma data set is composed of 2000 genes and 62 samples: 40 colon tumor samples and 22 normal colon tissue samples. We used the same preprocessing technique illustrated in [10] . Single linear SVMs trained using the entire set of gene expression data achieved an error of 17.74 ± 10.87 % according to a 5-fold cross validation evaluation of the generalization error. With random subspace ensembles of linear SVMs, we obtained the minimum of the test error using 64-dimensional subspaces, but also with 16 to 1024-dimensional subspaces results are equal or better than single SVMs trained on the entire feature space (Fig 1 a) . The ensembles start to learn when 8 random genes are selected, and if we apply at least 16 gene-subspaces we achieve a reasonable specificity at the expense of a low decrement of the sensitivity (Fig 1 b) . 
Medulloblastoma clinical outcome prediction
The second problem concerns with the prediction of medulloblastoma clinical outcome by gene expression profiling. The data set is composed of 60 samples, with 39 survivors and 21 treatment failures. We selected about 4000 genes from the original 7129, obtained by the same preprocessing techniques adopted in the original work [11] .
Single linear SVMs trained using the entire set of gene expression data achieved an error of 28.33 ± 9.50 % according to a 5-fold cross validation estimate of the generalization error.
Random subspace ensembles outperform single SVMs trained on the entire set of the gene expression data. The minimum of the test error is registered with 256-dimensional subspaces, but in this case we need from 128 to 512-dimensional random subsets of genes to achieve better results than single SVMs (Fig 2 a) . In all cases we obtained low sensitivity (slightly better for subspaces between 128 and 512 dimensions), and large specificity for a large range of randomly selected genes (Fig 2 b) . Moreover our ensemble approach on medulloblastoma clinical outcome prediction achieves better accuracy and sensitivity with respect to SVMs combined with feature selection methods proposed in [11] .
Conclusions
Random subspace ensembles outperform single SVMs on both the considered classification tasks. The null hypothesis that the random subspace ensemble has the same error rate as single SVMs is rejected at 0.05 significance level according to the 5-fold cross validated paired t-test for both the Colon and Medulloblastoma data sets.
Moreover we achieve better results with random subspace ensembles for a quite large choice of the subspace dimension ( Fig. 1 and 2 ). Only for subspaces of very low dimension the quality of the resulting classifier is low.
The encouraging experimental results suggest to apply random subspace techniques to high-dimensional bio-molecular diagnostic problems, possibly combining the proposed ensemble approach with state-of-the-art feature selection methods.
